研发人员增加工资、备_老虎社区_美港股上老虎

2022-12-10

研发人员增加工资、备货增多，这些是常规现象，这算理由吗？到是临近年底回款速度慢，说明销售和技术人员服务有所欠缺。医院和科研机构大额资金一般都是年度执行计划，用不掉说明验收等程序上还不符合拨付规定。酒虽香但也要吆喝啊，光知道加工资能行吗？

直击业绩会 | 联影医疗(688271.SH)：贴息贷款政策的拉动作用在短期内对四季度收入确认影响有限

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

Cherry樱桃
2022-12-10
Cherry樱桃
好
恒元
2022-12-10
恒元
1
figotan
2022-12-10
figotan
赞
用咯
2022-12-10
用咯
额额
ArthurSune
2022-12-10
ArthurSune
赞
梓坚
2022-12-10
梓坚
👍👍

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":629520300,"tweetId":"629520300","gmtCreate":1670627574200,"gmtModify":1670627576422,"author":{"id":3566783132096728,"authorId":3566783132096728,"authorIdStr":"3566783132096728","name":"滨浦八虎","avatar":"https://static.tigerbbs.com/bddd483a695fc16dec7a90cbc678aa24","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":11,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>研发人员增加工资、备货增多，这些是常规现象，这算理由吗？到是临近年底回款速度慢，说明销售和技术人员服务有所欠缺。医院和科研机构大额资金一般都是年度执行计划，用不掉说明验收等程序上还不符合拨付规定。酒虽香但也要吆喝啊，光知道加工资能行吗？</p></body></html>","htmlText":"<html><head></head><body><p>研发人员增加工资、备货增多，这些是常规现象，这算理由吗？到是临近年底回款速度慢，说明销售和技术人员服务有所欠缺。医院和科研机构大额资金一般都是年度执行计划，用不掉说明验收等程序上还不符合拨付规定。酒虽香但也要吆喝啊，光知道加工资能行吗？</p></body></html>","text":"研发人员增加工资、备货增多，这些是常规现象，这算理由吗？到是临近年底回款速度慢，说明销售和技术人员服务有所欠缺。医院和科研机构大额资金一般都是年度执行计划，用不掉说明验收等程序上还不符合拨付规定。酒虽香但也要吆喝啊，光知道加工资能行吗？","highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":6,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/629520300","repostId":2290286025,"repostType":2,"repost":{"id":"2290286025","pubTimestamp":1670583433,"share":"https://www.laohu8.com/m/news/2290286025?lang=&edition=full","pubTime":"2022-12-09 18:57","market":"us","language":"zh","title":"直击业绩会 | 联影医疗(688271.SH)：贴息贷款政策的拉动作用在短期内对四季度收入确认影响有限","url":"https://stock-news.laohu8.com/highlight/detail?id=2290286025","media":"智通财经","summary":"智通财经APP获悉，12月9日，联影医疗在三季度业绩说明会上表示，前三季度毛利率同比下降，主要是受国际经济形势影响，液氦及部分元器件等原材料采购成本有所上升。从业绩来看，前三季度，联影医疗实现营业收入58.59亿元，较上年同期增长25.55%；毛利率同比去年下降4.95个百分点，由去年50.75%下降至45.80%。","content":"<html><body><p>智通财经APP获悉，12月9日，<a href=\"https://laohu8.com/S/688271\">联影医疗</a>(688271.SH)在三季度业绩说明会上表示，<strong>前三季度毛利率同比下降，主要是受国际经济形势影响，液氦及部分元器件等原材料采购成本有所上升。</strong>另，部分高端产品的销售环节较多，受疫情影响较大，导致收入确认有所延迟。此外，联影医疗也坦言，因为大型影像设备交付、安装、以及验收的长周期特点，<strong>贴息贷款政策的拉动作用在短期内对公司的第四季度收入确认影响有限。</strong></p><p>联影医疗指出，从整体上来看，9月的贴息贷款政策带动了医疗设备采购需求的上升。在需求方面，公司看到的情况主要分为下面三种：1）此次政策出台前，本年度已经有了采购计划，但受疫情影响还未实际执行的医院，相关的采购需求将借力此次贴息贷款政策得到实施；2）部分医院、科研院所等终端用户综合评估自身的运营情况、未来的需求、潜在的经济效益等因素，将明年内有计划的项目，利用此次贴息政策，提前到今年内执行；3）部分医院、科研院所对高端和超高端设备的新增采购需求。</p><p>从业绩来看，前三季度，联影医疗实现营业收入58.59亿元，较上年同期增长25.55%；毛利率同比去年下降4.95个百分点，由去年50.75%下降至45.80%。</p><p><strong>经营活动产生的现金流量净额较去年同比有所下降，联影医疗表示，主要是由于研发人员的增加导致职工薪酬支出上涨</strong>，针对第四季度销售预测的备货导致经营活动现金流出较多，以及部分地区受疫情影响回款速度有所放缓，造成经营活动产生的现金流量净额有所下降。</p><p>海外方面，据悉，今年以来，联影医疗在国际市场取得了持续性突破，实现接近150%的同比增长，海外区域的收入占比也由去年同期的6.3%提升至12.6%。</p><p>联影医疗称，未来公司将充分利用业界领先的技术及全线产品的覆盖能力，集中精力实现海外市场各区域的高端窗口医院装机，树立品牌影响力，快速成为重点市场的核心参与者，并精耕细作。整合相关资源，建立维护区域窗口医院， 强化技术差异和临床价值，树立好公司在当地的品牌形象认知度和影响力。同时通过当地重要代理商渠道，积极拓宽业务合作方式，实现中高端产品和经济型产品量的覆盖，增强联影的综合竞争能力。</p></body></html>","source":"stock_zhitongcaijing","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>直击业绩会 | 联影医疗(688271.SH)：贴息贷款政策的拉动作用在短期内对四季度收入确认影响有限</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n直击业绩会 | 联影医疗(688271.SH)：贴息贷款政策的拉动作用在短期内对四季度收入确认影响有限\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-12-09 18:57 北京时间&nbsp;&nbsp;&nbsp;<a href=http://www.zhitongcaijing.com/content/detail/845161.html><strong>智通财经</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>智通财经APP获悉，12月9日，联影医疗(688271.SH)在三季度业绩说明会上表示，前三季度毛利率同比下降，主要是受国际经济形势影响，液氦及部分元器件等原材料采购成本有所上升。另，部分高端产品的销售环节较多，受疫情影响较大，导致收入确认有所延迟。此外，联影医疗也坦言，因为大型影像设备交付、安装、以及验收的长周期特点，贴息贷款政策的拉动作用在短期内对公司的第四季度收入确认影响有限。联影医疗指出，...</p>\n\n<a href=\"http://www.zhitongcaijing.com/content/detail/845161.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"688271":"联影医疗","BK0251":"专用设备"},"source_url":"http://www.zhitongcaijing.com/content/detail/845161.html","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2290286025","content_text":"智通财经APP获悉，12月9日，联影医疗(688271.SH)在三季度业绩说明会上表示，前三季度毛利率同比下降，主要是受国际经济形势影响，液氦及部分元器件等原材料采购成本有所上升。另，部分高端产品的销售环节较多，受疫情影响较大，导致收入确认有所延迟。此外，联影医疗也坦言，因为大型影像设备交付、安装、以及验收的长周期特点，贴息贷款政策的拉动作用在短期内对公司的第四季度收入确认影响有限。联影医疗指出，从整体上来看，9月的贴息贷款政策带动了医疗设备采购需求的上升。在需求方面，公司看到的情况主要分为下面三种：1）此次政策出台前，本年度已经有了采购计划，但受疫情影响还未实际执行的医院，相关的采购需求将借力此次贴息贷款政策得到实施；2）部分医院、科研院所等终端用户综合评估自身的运营情况、未来的需求、潜在的经济效益等因素，将明年内有计划的项目，利用此次贴息政策，提前到今年内执行；3）部分医院、科研院所对高端和超高端设备的新增采购需求。从业绩来看，前三季度，联影医疗实现营业收入58.59亿元，较上年同期增长25.55%；毛利率同比去年下降4.95个百分点，由去年50.75%下降至45.80%。经营活动产生的现金流量净额较去年同比有所下降，联影医疗表示，主要是由于研发人员的增加导致职工薪酬支出上涨，针对第四季度销售预测的备货导致经营活动现金流出较多，以及部分地区受疫情影响回款速度有所放缓，造成经营活动产生的现金流量净额有所下降。海外方面，据悉，今年以来，联影医疗在国际市场取得了持续性突破，实现接近150%的同比增长，海外区域的收入占比也由去年同期的6.3%提升至12.6%。联影医疗称，未来公司将充分利用业界领先的技术及全线产品的覆盖能力，集中精力实现海外市场各区域的高端窗口医院装机，树立品牌影响力，快速成为重点市场的核心参与者，并精耕细作。整合相关资源，建立维护区域窗口医院， 强化技术差异和临床价值，树立好公司在当地的品牌形象认知度和影响力。同时通过当地重要代理商渠道，积极拓宽业务合作方式，实现中高端产品和经济型产品量的覆盖，增强联影的综合竞争能力。","news_type":1},"isVote":1,"tweetType":1,"viewCount":1185,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"upFlag":false,"length":226,"xxTargetLangEnum":"ZH_CN"},"commentList":[{"id":7776604,"gmtCreate":1670628981220,"gmtModify":1670628994403,"authorId":3576060031289725,"author":{"id":3576060031289725,"authorId":3576060031289725,"name":"Cherry樱桃","avatar":"https://static.tigerbbs.com/59f445d9e00579e31801f7cd8afb02e9","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":629520300,"type":1,"supId":0,"prevId":0,"content":"好","text":"好","html":"好","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0},{"id":7776602,"gmtCreate":1670628970263,"gmtModify":1670628983189,"authorId":4124781330907252,"author":{"id":4124781330907252,"authorId":4124781330907252,"name":"恒元","avatar":"https://static.tigerbbs.com/65a71ca0446d5472b5ad841d95ec880c","vip":1,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":629520300,"type":1,"supId":0,"prevId":0,"content":"1","text":"1","html":"1","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0},{"id":7776594,"gmtCreate":1670628712676,"gmtModify":1670628726150,"authorId":305267755765347,"author":{"id":305267755765347,"authorId":305267755765347,"name":"figotan","avatar":"https://static.tigerbbs.com/a45302f7d9a49b5165446d2bb3c44c91","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":629520300,"type":1,"supId":0,"prevId":0,"content":"赞","text":"赞","html":"赞","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0},{"id":7776589,"gmtCreate":1670628596991,"gmtModify":1670628610336,"authorId":3446714706796639,"author":{"id":3446714706796639,"authorId":3446714706796639,"name":"用咯","avatar":"https://static.tigerbbs.com/63b6854e03ba975d52b3a64c24c1b7fe","vip":1,"hat":"https://static.tigerbbs.com/75944ad144f2566ba526ce9b292d3cd2","crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":629520300,"type":1,"supId":0,"prevId":0,"content":"额额","text":"额额","html":"额额","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0},{"id":7776585,"gmtCreate":1670628471367,"gmtModify":1670628484843,"authorId":64031554465398,"author":{"id":64031554465398,"authorId":64031554465398,"name":"ArthurSune","avatar":"https://static.tigerbbs.com/6e21614ffcaf5aaa61c457e61dec3955","vip":1,"currentWearingBadge":{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.41%","individualDisplayEnabled":0,"individualDisplaySort":0,"categoryType":1101},"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":629520300,"type":1,"supId":0,"prevId":0,"content":"赞","text":"赞","html":"赞","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0},{"id":7776578,"gmtCreate":1670628057978,"gmtModify":1670628071614,"authorId":3581646737212013,"author":{"id":3581646737212013,"authorId":3581646737212013,"name":"梓坚","avatar":"https://static.tigerbbs.com/dc60101ae2a157654c11b14c2d659432","vip":1,"hat":"https://static.tigerbbs.com/acebb9722806729a38c10fe7cde46b94","crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":629520300,"type":1,"supId":0,"prevId":0,"content":"👍👍","text":"👍👍","html":"👍👍","likeSize":1,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"invalid","coins":0,"score":0}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/629520300"}